Saba Capital Management’s Genius Sports Limited Redeemable Warrants, each whole warrant exercisable for one Ordinary Share each at an exercise price of $11. 50 per share GENI.WS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
Sell
-38,851
Closed -$27K 1016
2022
Q3
$27K Buy
38,851
+23,851
+159% +$16.2K ﹤0.01% 921
2022
Q2
$6K Buy
+15,000
New +$9.43K ﹤0.01% 1073

Other funds holding GENI.WS

Saba Capital Management's GENI.WS Position: Q4 2022 in Review

Saba Capital Management sold out of Genius Sports Limited Redeemable Warrants, each whole warrant exercisable for one Ordinary Share each at an exercise price of $11. 50 per share (GENI.WS) in Q4 2022, closing a stake of 38,851 shares — an estimated $27K sold.

Saba Capital Management first reported a position in GENI.WS in Q2 2022 and held it in 2 quarters. The position peaked at $27K in Q3 2022. 14 funds tracked by Wall St. Rank hold GENI.WS as of Q4 2022.

  • Saba Capital Management reported no remaining Genius Sports Limited Redeemable Warrants, each whole warrant exercisable for one Ordinary Share each at an exercise price of $11. 50 per share position as of Q4 2022 after selling out during the quarter.
  • Saba Capital Management sold 38,851 Genius Sports Limited Redeemable Warrants, each whole warrant exercisable for one Ordinary Share each at an exercise price of $11. 50 per share shares in Q4 2022, an estimated $27K.
  • Saba Capital Management first reported a position in Genius Sports Limited Redeemable Warrants, each whole warrant exercisable for one Ordinary Share each at an exercise price of $11. 50 per share in Q2 2022 and held it in 2 quarters.
  • Saba Capital Management's Genius Sports Limited Redeemable Warrants, each whole warrant exercisable for one Ordinary Share each at an exercise price of $11. 50 per share position peaked at $27K in Q3 2022.
  • 14 funds tracked by Wall St. Rank held Genius Sports Limited Redeemable Warrants, each whole warrant exercisable for one Ordinary Share each at an exercise price of $11. 50 per share as of Q4 2022.

Based on Saba Capital Management's 13F filing for Q4 2022, filed 14 Feb 2023.